Trial of SAVVY Vaginal Gel and HIV in Nigeria

Mise à jour : Il y a 5 ans
Référence : NCT00130078

Femme Homme

  • | Pays :
  • Nigeria
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Heterosexual contact is now the primary route of transmission for HIV worldwide. This study is a phase 3 trial designed to determine the effectiveness and safety of the 1.0% C31G (SAVVY) vaginal gel for the prevention of male-to-female transmission of HIV among women at high risk.


Critère d'inclusion

  • HIV Infections

Liens